Article ID Journal Published Year Pages File Type
8844731 Papillomavirus Research 2018 8 Pages PDF
Abstract
Screening for anal HPV and treatment of anal HSIL in patients with cervical cancer is cost-effective, prevents anal cancer and reduces anal cancer deaths.
Related Topics
Life Sciences Immunology and Microbiology Virology
Preview
Patients with newly diagnosed cervical cancer should be screened for anal human papilloma virus and anal dysplasia: Results of a pilot study using a STELLA computer simulation and economic model
Authors
, ,